Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)
Clinical trial NCT03059797 · COMPLETED
Trial details
- NCT number
- NCT03059797
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2018-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.